Dialogue Health Technologies Inc.
DLHTF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $185,386 | $225,466 | $263,081 | $267,604 |
| - Cash | $62,697 | $104,296 | $42,067 | $24,612 |
| + Debt | $1,854 | $2,926 | $3,469 | $3,549 |
| Enterprise Value | $124,543 | $124,096 | $224,482 | $246,540 |
| Revenue | $87,132 | $68,049 | $35,802 | $10,089 |
| % Growth | 28% | 90.1% | 254.9% | – |
| Gross Profit | $43,344 | $28,807 | $14,393 | $5,486 |
| % Margin | 49.7% | 42.3% | 40.2% | 54.4% |
| EBITDA | -$21,310 | -$249,213 | -$17,323 | -$10,929 |
| % Margin | -24.5% | -366.2% | -48.4% | -108.3% |
| Net Income | -$25,953 | -$251,351 | -$20,231 | -$12,043 |
| % Margin | -29.8% | -369.4% | -56.5% | -119.4% |
| EPS Diluted | -0.39 | -4.48 | -0.31 | -0.19 |
| % Growth | 91.3% | -1,345.2% | -63.2% | – |
| Operating Cash Flow | -$15,569 | -$23,279 | -$18,412 | -$12,985 |
| Capital Expenditures | -$454 | -$738 | -$942 | -$603 |
| Free Cash Flow | -$16,023 | -$24,017 | -$19,354 | -$13,587 |